Megakaryocytes platelets inducing agent being useful in treating diseases involving thrombopenia. Megakaryocytes platelets inducing agent is an inducing agent for megakaryocytes and or platelets from pluripotent stem cells.
TA-1887 is a new type of selective inhibitor of sglt2 for the treatment of type 2 diabetes. It has a significant hypoglycemic effect in KK (HF-KK) mice fed a high-fat diet. TA-1887 has good pharmacokinetic characteristics and significantly increases UGE